Regulus Therapeutics

+$0.0187 (+1.94%) Today
-$0.0077 (-0.78%) As of 8:21 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RGLS and other ETFs, options, and stocks.

About RGLS

Regulus Therapeutics Inc. Common Stock, also called Regulus Therapeutics, is a clinical-stage biopharmaceutical company, which engages in the discovery and development of drugs targeting microRNAs.

CEO
Joseph P. Hagan
Employees
24
Headquarters
San Diego, California
Founded
2007

RGLS Key Statistics

Market Cap
92.70M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
12.36M
High Today
$1.00
Low Today
$0.96
Open Price
$0.9947
Volume
3.16M
52 Week High
$2.32
52 Week Low
$0.4222

RGLS Earnings

-$0.26
-$0.17
-$0.09
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 9, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure